Candriam S.C.A. Vera Therapeutics, Inc. Transaction History
Candriam S.C.A.
- $16.9 Billion
- Q4 2024
A detailed history of Candriam S.C.A. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 365,999 shares of VERA stock, worth $12.4 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
365,999
Previous 450,992
18.85%
Holding current value
$12.4 Million
Previous $19.9 Million
22.33%
% of portfolio
0.09%
Previous 0.12%
Shares
4 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
57.9MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$147 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$134 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$113 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$101 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$100 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $919M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...